Evidence map›Paper›PMID 37448407›Full record

ArticleCureus2023

Cystatin C as a Potential Blood Biomarker for Sarcoidosis: A Case Report.

Shohei Fukunaga, Kenichi Itoga, Hirotaka Sonoda, Yuki Hoshino, Ryuichi Yoshimura, Masahiro Egawa, Takafumi Ito, Kazuaki Tanabe

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shohei FukunagaNephrology, Shimane University Hospital, Izumo, JPN.
Kenichi ItogaNephrology, Shimane University Hospital, Izumo, JPN.
Hirotaka SonodaNephrology, Shimane University Hospital, Izumo, JPN.
Yuki HoshinoNephrology, Shimane University Hospital, Izumo, JPN.
Ryuichi YoshimuraNephrology, Shimane University Hospital, Izumo, JPN.
Masahiro EgawaNephrology, Shimane University Hospital, Izumo, JPN.
Takafumi ItoNephrology, Shimane University Hospital, Izumo, JPN.
Kazuaki TanabeInternal Medicine, Shimane University Faculty of Medicine, Izumo, JPN.
Shimane University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcoidosis is a multi-organ medical condition that is characterized by the formation of granulomas. We aimed to identify a correlation between each sarcoidosis blood biomarker and cystatin C (Cys-C) in sarcoidosis patients. We report a case of a 60-year-old man with sarcoidosis. The correlation between his Cys-C and each blood biomarker level and that between each blood biomarker and serum creatinine levels were determined using linear regression. Serum Cys-C correlated with each blood biomarker of sarcoidosis, while creatinine did not. These findings suggest that Cys-C is a potential blood biomarker for sarcoidosis.

Indexed as

angiotensin-converting enzymecystatin clysozymesarcoidosissoluble il-2 receptor

Identifiers

PMID37448407
PMCPMC10337699
OpenAlexW4380364130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.